SPIRO LIFECARE IBUPROFEN ibuprofen 200mg softgel capsule Australia - English - Department of Health (Therapeutic Goods Administration)

spiro lifecare ibuprofen ibuprofen 200mg softgel capsule

intermed laboratories pty ltd - ibuprofen, quantity: 200 mg - capsule, soft - excipient ingredients: potassium hydroxide; lecithin; purified water; gelatin; fast green fcf; partially dehydrated liquid sorbitol; macrogol 600 - temporary relief of acute pain where inflammation is present such as back, neck and muscle pain. temporary relief of headache, migraine, period pain, dental pain, sore throat, arthritis pain and pain associated with the common cold and flu. reduces fever.

BLISTEX ENHANCEMENT SERIES (ULTRA-RICH HYDRATION AND LIP VIBRANCE)- dimethicone, octinoxate and oxybenzone kit United States - English - NLM (National Library of Medicine)

blistex enhancement series (ultra-rich hydration and lip vibrance)- dimethicone, octinoxate and oxybenzone kit

blistex inc. - dimethicone (unii: 92ru3n3y1o) (dimethicone - unii:92ru3n3y1o), octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51), oxybenzone (unii: 95oos7ve0y) (oxybenzone - unii:95oos7ve0y) - dimethicone 2 g in 100 g - - temporarily protects and helps relieve chapped or cracked lips - helps prevent sunburn - temporarily protects and helps relieve chapped or cracked lips - helps prevent sunburn

Duo Medical DuoFoam Post-op Dressing Singapore - English - HSA (Health Sciences Authority)

duo medical duofoam post-op dressing

duo medical pte. ltd. - general & plastic surgery - duofoam post-op is an all-in-one thin foam dressing. it’s designed for a wide range of low-exuding wounds. chronic wounds, like diabetic foot ulcers and pressure ulcers. and acute secondary healing wounds, such as postoperative incisions or traumatic wounds (incl. sutured wounds).

Orochemie FD 366 Sensitive Disinfection of Sensitive Surfaces Singapore - English - HSA (Health Sciences Authority)

orochemie fd 366 sensitive disinfection of sensitive surfaces

ican consultation pte. ltd. - general hospital - fd 366 sensitive is an aldhehyde-free, ready-to-use solution for the quick disinfection of sensitive surfaces of invasive and non-invasive medical devices such as plastic and artificial leather covers of treatment units, acrylic glass, device covers, mixing beakers (including those of vacuum mixers), hose trays, rinsing bowls, etc. furthermore, fd 366 sensitive is also suitable for the control panels of treatment units or xr x-ray developing machines. fd 366 sensitive dries off quickly.

Pulmodyne GO-PAP Singapore - English - HSA (Health Sciences Authority)

pulmodyne go-pap

aris integrated medical pte. ltd. - general hospital - to provide cpap to spontaneous breathing adult (>30kg) patients in the hospital & pre-hospital (ems) environment.

Diprospan 500mg+2mg Suspension for injection Philippines - English - FDA (Food And Drug Administration)

diprospan 500mg+2mg suspension for injection

ohme (i.a.) cirharp & dohme opionateeip ichering plough & dohme (i.a - betamethasone (as dipropionate) , betamethasone (as sodium phosphate) - suspension for injection - 500mg+2mg

PULMOZYME 1MG/ML SOLUTION Canada - English - Health Canada

pulmozyme 1mg/ml solution

hoffmann-la roche limited - dornase alfa - solution - 1mg - dornase alfa 1mg - enzymes

DULOXETINE capsule, delayed release United States - English - NLM (National Library of Medicine)

duloxetine capsule, delayed release

zydus lifesciences limited - duloxetine hydrochloride (unii: 9044sc542w) (duloxetine - unii:o5tnm5n07u) - duloxetine 20 mg - duloxetine delayed-release capsules are indicated for the treatment of: -   major depressive disorder [see clinical studies (14.1)] -   generalized anxiety disorder [see clinical studies (14.2)] -   diabetic peripheral neuropathy [see clinical studies (14.3)] -   chronic musculoskeletal pain [see clinical studies (14.5)] monoamine oxidase inhibitors (maois) the use of maois intended to treat psychiatric disorders with duloxetine or within 5 days of stopping treatment with duloxetine is contraindicated because of an increased risk of serotonin syndrome. the use of duloxetine within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated [see dosage and administration (2.8) and warnings and precautions (5.4)] . starting duloxetine in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome [see dosage and administration (2.9) and  warnings and precautions (5.4)] . pregn